Phase I Dose‐Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors

類似資料

• A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid Tumors
  著者:: Ma, Yuxiang, 等
  出版事項: (2020)
• Phase I Dose‐Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors
  著者:: Shiah, Her‐Shyong, 等
  出版事項: (2020)
• Phase I Dose‐Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors
  著者:: Wheler, Jennifer, 等
  出版事項: (2017)
• Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors
  著者:: Olszanski, Anthony J., 等
  出版事項: (2016)
• Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors
  著者:: Bendell, Johanna C., 等
  出版事項: (2018)